PGICX
Price
$18.66
Change
+$0.11 (+0.59%)
Updated
Aug 6 closing price
Net Assets
135.38M
RMFEX
Price
$59.78
Change
-$0.00 (-0.00%)
Updated
Aug 6 closing price
Net Assets
108.54B
Interact to see
Advertisement

PGICX vs RMFEX

Header iconPGICX vs RMFEX Comparison
Open Charts PGICX vs RMFEXBanner chart's image
Virtus KAR Equity Income C
Price$18.66
Change+$0.11 (+0.59%)
VolumeN/A
Net Assets135.38M
American Funds American Mutual R4
Price$59.78
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets108.54B
PGICX vs RMFEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PGICX vs. RMFEX commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGICX is a Hold and RMFEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 109B vs. PGICX (135M). PGICX pays higher dividends than RMFEX: PGICX (2.46) vs RMFEX (1.51). PGICX was incepted earlier than RMFEX: PGICX (28 years) vs RMFEX (23 years). PGICX (2.16) is less costly to investors than RMFEX (0.62). RMFEX is a more actively managed with annual turnover of: 31.00 vs. PGICX (17.00). RMFEX has a lower initial minimum investment than PGICX: RMFEX (250) vs PGICX (2500). PGICX annual gain was more profitable for investors over the last year : 13.83 vs. RMFEX (11.05). RMFEX return over 5 years is better than : 56.76 vs. PGICX (0.71).
PGICXRMFEXPGICX / RMFEX
Total Expense Ratio1.950.62315%
Annual Report Gross Expense Ratio2.160.62348%
Fund Existence28 years23 years-
Gain YTD9.6989.675100%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets135M109B0%
Annual Yield % from dividends2.461.51163%
Returns for 1 year13.8311.05125%
Returns for 3 years13.9526.8752%
Returns for 5 years0.7156.761%
Returns for 10 years23.9885.7228%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMOPX36.31N/A
N/A
Patient Opportunity C
MGINX10.78N/A
N/A
DWS Global Macro Inst
NSBFX64.62N/A
N/A
Nuveen Dividend Growth R6
NEQAX12.72N/A
N/A
Neuberger Berman U.S. Equity Impact A
REFGX7.97-0.01
-0.13%
Emerging Markets Equities Fund R-6